University of Michigan Rogel Cancer Center: How Race Impacts Patients' Response to Cancer Immunotherapy
November 26, 2024
November 26, 2024
ANN ARBOR, Michigan, Nov. 26 (TNSres) -- The University of Michigan Rogel Cancer Center issued the following news release:
* * *
First large-scale analysis finds immune checkpoint inhibitors are equally effective in Black, white patients; Black patients have fewer side effects
* * *
Clinical trials testing cancer immunotherapies significantly under-represented Black patients. So while these treatments have resulted in dramatically improved outc . . .
* * *
First large-scale analysis finds immune checkpoint inhibitors are equally effective in Black, white patients; Black patients have fewer side effects
* * *
Clinical trials testing cancer immunotherapies significantly under-represented Black patients. So while these treatments have resulted in dramatically improved outc . . .